Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04298216
Other study ID # 55097
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2024
Est. completion date December 2024

Study information

Verified date April 2023
Source Stanford University
Contact Aaron Deng, BS
Phone (408)914-5494
Email adeng1@stanford.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Currently, in order to visualize the inferior vena cava (IVC) of the heart using ultrasound, physicians traditionally place the ultrasound probe onto the "Subcostal" area which is located below the chest in the upper abdomen area. In this location, the pressure from the ultrasound probe is often uncomfortable for adults, and even more so for pediatric patients. Previous research and physician experience have demonstrated that it is possible to visualize the heart in the "transhepatic" area which is located under the arm on the side of the chest. By placing the ultrasound probe in this location, it is more comfortable for the patient when applying pressure, and this study aims to prove the effectiveness of visualizing the heart through this new location.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: 1. Be between ages of 2-18 years of age 2. Have parental consent 3. located at an inpatient/outpatient facility at LPCH 4. Be hemodynamically stable Exclusion Criteria: 1. Emergent Surgical Procedures 2. BMI greater than 24

Study Design


Intervention

Diagnostic Test:
Ultrasound Analysis of Inferior Vena Cavae (IVC)
Novel Operators will attempt to visualize the Inferior Vena Cavae through two different views on the patient's body. The images taken will be interpreted by an expert ultrasound user to determine if the novel operator was successful in locating and evaluating the IVC.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Outcome

Type Measure Description Time frame Safety issue
Primary Time Novel Operators will be timed from the point at which the probe is placed until the image has been and will be evaluated between both the control and experimental groups. For the entirety of the ultrasound procedure.
Primary Accuracy of the IVC Analysis Novel Operators will be evaluated by the ultrasound expert who will confirm clinical success in locating the IVC. For the entirety of the ultrasound procedure.
See also
  Status Clinical Trial Phase
Recruiting NCT04914455 - Transhepatic Echography for Fluid Responsiveness After Cardiovascular Surgery
Completed NCT03266250 - Transthoracic Echocardiography of Inferior Vena Cava Before Spinal Anesthesia Can Predict Hypotension